Torsten Tonn
About
Torsten Tonn is a scholar working on Immunology, Oncology and Hematology.
According to data from OpenAlex, Torsten Tonn has authored 162 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 65 papers in Oncology and 38 papers in Hematology. Recurrent topics in Torsten Tonn's work include Immune Cell Function and Interaction (59 papers), CAR-T cell therapy research (57 papers) and Hematopoietic Stem Cell Transplantation (20 papers). Torsten Tonn is often cited by papers focused on Immune Cell Function and Interaction (59 papers), CAR-T cell therapy research (57 papers) and Hematopoietic Stem Cell Transplantation (20 papers). Torsten Tonn collaborates with scholars based in Germany, United States and United Kingdom. Torsten Tonn's co-authors include Stefanie Dimmeler, Andreas M. Zeiher, Volker Schächinger, Winfried S. Wels, Birgit Aßmus, Erhard Seifried, Hans Klingemann, Sandra Erbs, Rainer Hambrecht and Sven Becker and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.
In The Last Decade
Torsten Tonn
154 papers receiving 9.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Torsten Tonn Germany | 46 | 3.6k | 3.5k | 2.9k | 2.9k | 2.7k | 162 | 9.7k | ||
| Weidong Han China | 63 | 4.3k 1.2× | 7.4k 2.1× | 6.2k 2.1× | 1.6k 0.5× | 1.6k 0.6× | 267 | 15.0k | ||
| Joyce Bischoff United States | 62 | 796 0.2× | 2.1k 0.6× | 5.1k 1.7× | 4.8k 1.7× | 1.1k 0.4× | 161 | 12.0k | ||
| Suzanne M. Watt United Kingdom | 46 | 1.2k 0.3× | 1.1k 0.3× | 2.8k 1.0× | 1.3k 0.4× | 1.7k 0.6× | 145 | 6.6k | ||
| Reza Abdi United States | 43 | 2.0k 0.6× | 1.1k 0.3× | 1.7k 0.6× | 2.0k 0.7× | 1.2k 0.5× | 176 | 6.7k | ||
| Dieter Hoelzer Germany | 62 | 1.9k 0.5× | 4.6k 1.3× | 4.6k 1.6× | 1.2k 0.4× | 4.6k 1.7× | 322 | 16.5k | ||
| Carmelo Carlo‐Stella Italy | 40 | 2.1k 0.6× | 3.0k 0.9× | 2.4k 0.8× | 1.1k 0.4× | 3.4k 1.3× | 350 | 9.1k | ||
| Koichi Hattori Japan | 33 | 1.3k 0.3× | 2.3k 0.7× | 4.9k 1.7× | 891 0.3× | 1.3k 0.5× | 64 | 7.7k | ||
| Leslie E. Silberstein United States | 43 | 2.8k 0.8× | 1.3k 0.4× | 2.8k 0.9× | 888 0.3× | 1.5k 0.5× | 116 | 7.9k | ||
| Karin Tarte France | 50 | 3.5k 1.0× | 2.8k 0.8× | 2.6k 0.9× | 1.1k 0.4× | 2.2k 0.8× | 177 | 8.4k | ||
| Steven M. Devine United States | 49 | 3.0k 0.8× | 3.4k 1.0× | 2.2k 0.8× | 1.1k 0.4× | 3.1k 1.1× | 318 | 11.0k |
Countries citing papers authored by Torsten Tonn
Since
Specialization
Citations
This map shows the geographic impact of Torsten Tonn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Tonn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Tonn more than expected).
Fields of papers citing papers by Torsten Tonn
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Torsten Tonn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Tonn. The network helps show where Torsten Tonn may publish in the future.
Co-authorship network of co-authors of Torsten Tonn
This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Tonn. A scholar is included among the top collaborators of Torsten Tonn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Tonn. Torsten Tonn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tonn, Torsten, et al.. (2024). HLA reduction of human T cells facilitates generation of immunologically multicompatible cellular products. Blood Advances. 8(13). 3416–3426.
2.
Jacobs, Miriam N., Kevin Cavanagh, Christophe Chesné, et al.. (2023). OECD workshop consensus report: Ethical considerations with respect to human derived products, specifically human serum, in OECD test guidelines. SHILAP Revista de lepidopterología. 5. 1140698–1140698.
3.
Kronstein‐Wiedemann, Romy, et al.. (2023). Long-COVID is Associated with Impaired Red Blood Cell Function. Hormone and Metabolic Research. 56(4). 318–323.
4.
Mata, Eduardo Sergio Oliveros, Markus Laube, Anja Feldmann, et al.. (2023). Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies. ACS Sensors. 8(2). 576–586.
5.
Ruscher, Claudia, Sarah McFarland, Anne Kopp, et al.. (2023). Ecological and clinical evidence of the establishment of West Nile virus in a large urban area in Europe, Berlin, Germany, 2021 to 2022. Eurosurveillance. 28(48).
6.
Zhang, Congcong, Pranav Oberoi, Malena Bodden, et al.. (2023). Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers. Cancer Immunology Immunotherapy. 72(9). 2905–2918.
7.
Michen, Susanne, Alexander Becker, Monika Füssel, et al.. (2022). NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme. International Journal of Molecular Sciences. 23(10). 5857–5857.
8.
Fakhfouri, Armaghan, Romy Kronstein‐Wiedemann, Torsten Tonn, et al.. (2019). Blood platelet enrichment in mass-producible surface acoustic wave (SAW) driven microfluidic chips. Lab on a Chip. 19(24). 4043–4051.
9.
Rahbari, Mohammad, Mathieu Pecqueux, Daniela E. Aust, et al.. (2019). Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes. Journal of Clinical Medicine. 8(5). 696–696.
10.
Bonsack, Maria, et al.. (2018). PRAME peptide‐specific CD8+ T cells represent the predominant response against leukemia‐associated antigens in healthy individuals. European Journal of Immunology. 48(8). 1400–1411.
11.
Wüstefeld, Liane, Daniela Winkler, Romy Kronstein‐Wiedemann, et al.. (2017). EV-3, an endogenous human erythropoietin isoform with distinct functional relevance. Scientific Reports. 7(1). 3684–3684.
12.
Zhang, Congcong, Michael C. Burger, Lukas Jennewein, et al.. (2015). ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma. JNCI Journal of the National Cancer Institute. 108(5).
13.
Russo, Elisa Maria de Sousa, et al.. (2010). Integration pattern of HIV-1 based lentiviral vector carrying recombinant coagulation factor VIII in Sk-Hep and 293T cells. Biotechnology Letters. 33(1). 23–31.
14.
Schächinger, Volker, Birgit Aßmus, Sandra Erbs, et al.. (2009). Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells Abrogates Adverse Left Ventricular Remodelling Post-Acute Myocardial Infarction: Insights from the Reinfusion of Enriched Progenitor Cells and Infarct Remodelling in Acute Myocardial Infarction (REPAIR-AMI) Trial. European Journal of Heart Failure. 11(10). 973–979.
15.
Erbs, Sandra, Axel Linke, Volker Schächinger, et al.. (2007). Restoration of Microvascular Function in the Infarct-Related Artery by Intracoronary Transplantation of Bone Marrow Progenitor Cells in Patients With Acute Myocardial Infarction. Circulation. 116(4). 366–374.
16.
Aßmus, Birgit, Volker Schächinger, Sandra Erbs, et al.. (2007). Abstract 695: The Quality Of Cell Isolation Determines Left Ventricular Contractile Recovery After Intracoronary Administration Of Bone Marrow-derived Progenitor Cells In Patients With AMI - Insights from the REPAIR-AMI Trial. Circulation. 116.
17.
Heinz, Stefan, et al.. (2007). Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter. Cytotherapy. 9(8). 785–794.
18.
Schächinger, Volker, Sandra Erbs, A. Elsasser, et al.. (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. European Heart Journal. 27(23). 2775–2783.
19.
Tonn, Torsten, Christian Herder, Sven Becker, Erhard Seifried, & Manuel Grez. (2002). Generation and Characterization of Human Hematopoietic Cell Lines Expressing Factor VIII. Journal of Hematotherapy & Stem Cell Research. 11(4). 695–704.
20.
Tonn, Torsten, Sven Becker, Ruth Esser, Dirk Schwabe, & Erhard Seifried. (2001). Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92. Journal of Hematotherapy & Stem Cell Research. 10(4). 535–544.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Weidong Han Breakdown of academic impact, for papers by Joyce Bischoff Breakdown of academic impact, for papers by Suzanne M. Watt Breakdown of academic impact, for papers by Reza Abdi Breakdown of academic impact, for papers by Dieter Hoelzer Breakdown of academic impact, for papers by Carmelo Carlo‐Stella Breakdown of academic impact, for papers by Koichi Hattori Breakdown of academic impact, for papers by Leslie E. Silberstein Breakdown of academic impact, for papers by Karin Tarte Breakdown of academic impact, for papers by Steven M. Devine